To investigate the effect of cell-specific superoxide generation after stroke with apocynin treatment, sections were simultaneously labelled with dihydroethidium and the activated microglia/macrophage marker OX-42 (Figure 4), or dihydroethidium, and the neuronal marker NeuN (Figure 5). The gene discussed is RBFOX3; the disease is Stroke.